Figini M - Search Results

1

Single-step purification of immunotoxins containing a high ionic charge ribosome inactivating protein clavin by carboxymethyl high-performance membrane chromatography.

Dosio F, Arpicco S, Canevari S, Figini M, Gastaldi D. Dosio F, et al. Among authors: figini m. J Chromatogr A. 1999 Jan 15;830(2):329-35. doi: 10.1016/s0021-9673(98)00933-9. J Chromatogr A. 1999. PMID: 10048197

2

Glycolipids carrying Le(y) are preferentially expressed on small-cell lung cancer cells as detected by the monoclonal antibody MLuC1.

Leoni F, Colnaghi MI, Canevari S, Ménard S, Colzani E, Facheris P, Figini M, Miotti S, Magnani JL. Leoni F, et al. Among authors: figini m. Int J Cancer. 1992 May 8;51(2):225-31. doi: 10.1002/ijc.2910510210. Int J Cancer. 1992. PMID: 1373704

3

Characterization of a mouse-human chimeric antibody to a cancer-associated antigen.

Orlandi R, Figini M, Tomassetti A, Canevari S, Colnaghi MI. Orlandi R, et al. Among authors: figini m. Int J Cancer. 1992 Oct 21;52(4):588-93. doi: 10.1002/ijc.2910520417. Int J Cancer. 1992. PMID: 1399142

4

Monoclonal antibodies by genetic engineering: novel reagents for in vivo diagnosis and therapy.

Canevari S, Furlan D, Mossa A, Figini M. Canevari S, et al. Among authors: figini m. Int J Biol Markers. 1993 Jul-Sep;8(3):147-50. doi: 10.1177/172460089300800302. Int J Biol Markers. 1993. PMID: 8277205 Review.

5

Approaches to implement bispecific antibody treatment of ovarian carcinoma.

Canevari S, Mezzanzanica D, Mazzoni A, Negri DR, Figini M, Ramakrishna V, Bolis G, Colnaghi MI. Canevari S, et al. Among authors: figini m. Cancer Immunol Immunother. 1997 Nov-Dec;45(3-4):187-9. doi: 10.1007/s002620050429. Cancer Immunol Immunother. 1997. PMID: 9435870 Free PMC article. Clinical Trial. No abstract available.

6

Panning phage antibody libraries on cells: isolation of human Fab fragments against ovarian carcinoma using guided selection.

Figini M, Obici L, Mezzanzanica D, Griffiths A, Colnaghi MI, Winter G, Canevari S. Figini M, et al. Cancer Res. 1998 Mar 1;58(5):991-6. Cancer Res. 1998. PMID: 9500461

7

Targeting of interleukin 2 to human ovarian carcinoma by fusion with a single-chain Fv of antifolate receptor antibody.

Melani C, Figini M, Nicosia D, Luison E, Ramakrishna V, Casorati G, Parmiani G, Eshhar Z, Canevari S, Colombo MP. Melani C, et al. Among authors: figini m. Cancer Res. 1998 Sep 15;58(18):4146-54. Cancer Res. 1998. PMID: 9751627

8

Transfer of chimeric receptor gene made of variable regions of tumor-specific antibody confers anticarbohydrate specificity on T cells.

Mezzanzanica D, Canevari S, Mazzoni A, Figini M, Colnaghi MI, Waks T, Schindler DG, Eshhar Z. Mezzanzanica D, et al. Among authors: figini m. Cancer Gene Ther. 1998 Nov-Dec;5(6):401-7. Cancer Gene Ther. 1998. PMID: 9917095

9

Humanized antibodies as potential drugs for therapeutic use.

Merluzzi S, Figini M, Colombatti A, Canevari S, Pucillo C. Merluzzi S, et al. Among authors: figini m. Adv Clin Path. 2000 Apr;4(2):77-85. Adv Clin Path. 2000. PMID: 11080787 Review.

10

Production and validation of the pharmacokinetics of a single-chain Fv fragment of the MGR6 antibody for targeting of tumors expressing HER-2.

Turatti F, Mezzanzanica D, Nardini E, Luison E, Maffioli L, Bambardieri E, de Lalla C, Canevari S, Figini M. Turatti F, et al. Among authors: figini m. Cancer Immunol Immunother. 2001 Feb;49(12):679-86. doi: 10.1007/s002620000162. Cancer Immunol Immunother. 2001. PMID: 11258794 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

142 results

Search Page

Filters